IMCVX | VMVAX | IMCVX / VMVAX | |
Total Expense Ratio | 0.79 | 0.07 | 1,129% |
Annual Report Gross Expense Ratio | 0.80 | 0.07 | 1,143% |
Fund Existence | 14 years | 14 years | - |
Gain YTD | 5.079 | 7.586 | 67% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250000 | 3000 | 8,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 182M | 31B | 1% |
Annual Yield % from dividends | 0.90 | 2.22 | 41% |
Returns for 1 year | -4.69 | 8.36 | -56% |
Returns for 3 years | 6.05 | 24.75 | 24% |
Returns for 5 years | 26.11 | 72.25 | 36% |
Returns for 10 years | -5.65 | 114.57 | -5% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DFAC | 37.79 | 0.74 | +2.00% |
Dimensional US Core Equity 2 ETF | |||
WLDR | 34.94 | 0.61 | +1.77% |
Affinity World Leaders Equity ETF | |||
UJAN | 41.48 | 0.28 | +0.67% |
Innovator US Equity Ultra Buff ETF™ Jan | |||
PBFR | 28.22 | 0.17 | +0.60% |
PGIM Laddered S&P 500 Buffer 20 ETF | |||
PCRB | 48.98 | 0.18 | +0.36% |
Putnam ESG Core Bond ETF |